The ACTN3 gene variant (R577X) is one of the most studied genetic markers in sports genetics. It encodes α-actinin-3, a protein expressed in fast-twitch (type II) muscle fibers. The R577X polymorphism results in a loss of function: individuals with the XX genotype produce no functional α-actinin-3. Research indicates that the RR genotype (functional) is overrepresented in elite sprint and power athletes, while the XX genotype is more common among endurance athletes. However, the effect size is small, accounting for only a modest fraction of performance variation. Many other genetic, environmental, and training factors are far more influential. Therefore, ACTN3 does not 'help' with sport in a direct, actionable sense; it is a statistical association, not a deterministic predictor. Consumer DNA tests often report this variant, but the practical utility for personalized training is limited. The evidence is based on candidate gene and genome-wide association studies (human-moderate), not on interventional trials. Overinterpreting ACTN3 results can lead to misguided expectations. Safety note: No direct risks, but genetic determinism should be avoided.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-002d8321dc3f30b1fba67c26